Aalborg

• A seamless, phase 1b/2 multiple ascending dose/proof of concept study of XTMAB-16 in patients with pulmonary sarcoidosis with or without ext … Not authorised
  2022-502877-41-00 9 Pulmonary sarcoidosis with or without extrapulmonary manifestations
• A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine when Given to Healthy Children 3 Month … Not authorised
  2024-516635-27-00 5 Varicella
• A Long-term Multicenter Open-label Study to Evaluate the Long-term Safety and Durability of Effect of XTMAB-16 in Patients With Pulmonary Sa … Pending
  2023-507590-18-00 4 Pulmonary sarcoidosis with or without extrapulmonary manifestations
• A multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis to compare active convent … Pending
  2024-516723-14-00 6 Rheumatoid Arthritis
• Efficacy, safety, and tolerability study of lunsekimig compared with placebo in adult participants with inadequately controlled chronic obst … Pending
  2024-518016-39-00 10 Respiratory tract diseases
• Study to Investigate the Efficacy, Safety, and Tolerability of Intravenous Gammagard Liquid (Immune Globulin Infusion, 10%) for Primary Infe … Pending
  2024-518420-80-00 5 Primary infection prophylaxis for secondary immunodeficiency (SID) in
• Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults with Non-cystic Fibrosis Bronchiectasis (NCFB) Pending
  2024-518821-13-00 4 Non-cystic Fibrosis Bronchiectasis
• Aciclovir for HSV-2 MENingitis: A double-blinded randomised controlled trial (AMEN) Pending
  2024-520042-31-00 6 HSV-2 meningitis
• OCEAN(a)-PreEvent - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction to Prevent first major cardiovascular Events Pending
  2025-520554-11-00 5 Cardiovascular Disease
• The MAYA2 trial Pending
  2025-521941-25-00 4 Colorectal cancer
• Study to assess the efficacy and safety of Rina-S plus standard of care compared to standard of care for maintenance treatment of participan … Pending
  2025-522167-15-00 5 Ovarian Cancer Platinum-Sensitive Ovarian Cancer (PSOC)
• Nordic PREdnisolon for VEstibular NeuriTis Study – an investigator-driven, triple blind, placebo controlled randomized trial Pending
  2025-522399-10-00 5 Vestibular neuritis
• Molecularly Tailored Therapy versus Standard Care in Advanced Pancreatic Cancer Pending
  2025-522431-34-00 4 Advanced pancreatic cancer
• A Study of Vepugratinib (LY3866288) in Participants with Cancer in the Urinary Tract ( FORAGER-2 ) Pending
  2025-522855-25-00 5 Urinary Bladder Neoplasms
• COPE-CP: The effect of Celecoxib on pain, quality of life, use of opioids, and inflammation in patients suffering from chronic pancreatitis Pending
  2025-522956-25-00 5 Chronic pancreatitis
• Phase 4, double-blind study evaluating the response on computed tomography (CT) lung density decline rates of Respreeza / Zemaira weekly for … Pending
  2025-522964-33-00 6 Alpha1-proteinase inhibitor deficiency
• A Randomized, Double-Blind, Phase 3 Study of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treat … Pending
  2025-523735-19-00 5 Metastatic Microsatellite Stable Colorectal Cancer
• Pulmonary Embolism & Anticoagulation Evaluation in Cancer Patient - PEACE Pending
  2025-524110-28-00 6 Incidental Subsegmental Pulmonary Embolism in cancer patients
• Self-Assessment Method for Statin side-effects Or Nocebo 2 Pending
  2025-524955-30-01 11 Cardiovascular diseases
• A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic P … Pending
  2025-525009-18-00 5 Pancreatic Ductal Adenocarcinoma
• RESET C2 Pending
  2026-525214-62-00 4 Localised dMMR Colon Cancer
• The OASE study Pending
  2026-525221-21-01 6 Rheumatoid arthritis
• A multicentre, adaptive, randomised, multidomain, platform trial for dose optimization in the treatment of adult patients with haematologica … Pending
  2026-525658-13-00 6 Haematological diseases; any disorder that primarily affects the blood
• A clinical trial of MK-1045 in people with B-cell acute lymphoblastic leukemia Recruiting
  2025-522267-15-00 10 2026-06-24 ​Relapsed/refractory B-cell Acute Lymphoblastic Leukemia​

Showing 1–24 of 325 trials